Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily LLY Bear 1X Shares

19.23
0.0000
Volume:- -
Turnover:- -
Market Cap:2.40M
PE:- -
High:19.23
Open:19.23
Low:19.23
Close:19.23
52wk High:28.08
52wk Low:16.40
Shares:125.00K
Float Shares:125.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:1.01
Dividend Rate:5.26%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Scotiabank Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 06

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Dow Jones
·
Aug 06

Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley

TIPRANKS
·
Aug 06

Wells Fargo Adjusts PT on Eli Lilly and Co. to $1,330 From $1,280, Maintains Overweight Rating

MT Newswires Live
·
Aug 06

Eli Lilly Buy Rating Reaffirmed as Obesity Leadership Drives Outlook; Price Target Raised to $1,344 from $1,334

TIPRANKS
·
Aug 06

Street View: Lilly Remains the Front-Runner as GLP-1 Demand Climbs

Reuters
·
Aug 06

Dow Hits New All-Time High: Investor Sentiment Improves, Fear Index In ‘Greed’ Zone

Benzinga Earnings
·
Aug 06

Eli Lilly (LLY) Stock Climbs On GLP 1 Strength And 86% Margin

Simply Wall St.
·
Aug 06

Eli Lilly : Leerink Partners Raises Target Price to $1,309.00 from $1,232.00

THOMSON REUTERS
·
Aug 06

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy

Dow Jones
·
Aug 06

Eli Lilly Earnings Call Highlights Powerful Growth Momentum

TIPRANKS
·
Aug 06

Global Equities Roundup: Market Talk

Dow Jones
·
Aug 06

Exchange Traded Funds Top 10 Percentage Gainers

Dow Jones
·
Aug 06

Eli Lilly & Co. Stock Advances 4.9%, Outperforms Peers

Dow Jones
·
Aug 06

Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.

Dow Jones
·
Aug 06

SpaceX, Alphabet, Nvidia, Micron, AMD, Uber, CVS, Lilly, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 06

How Ozempic Maker Novo Nordisk Blew Its Lead in GLP-1 Weight-Loss Drugs. Can Europe Compete in the High-Stakes Global Economy?

Dow Jones
·
Aug 06

Eli Lilly Doesn't Want to be Seen as 'Just an Obesity Company'

Dow Jones
·
Aug 06

Eli Lilly is Leading the Pharmaceutical Segment, CEO Says

Dow Jones
·
Aug 06

Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion

Benzinga Earnings
·
Aug 06